Mitochondrial disease
Gene: MRPS22
Variant affects mito function -> COPD
Variant doesn’t affect mito function -> OD
- Homozygous missense have been reported to cause either condition, functional evidence the only difference.
- Chet (missense/PTC) have been reported to cause COPD
- Structural analysis suggests that variant location could explain the different phenotypes: missense variants identified in individuals with the milder OD phenotype are situated in an internal region of MRPS22 while missense variants identified in individuals with the more severe COPD phenotype are postulated to indirectly cause disruption of protein:protein interfaces (this is from one report (PMID: 29566152) and more evidence is needed to confirm this)Created: 8 Jan 2021, 1:53 a.m. | Last Modified: 8 Jan 2021, 1:53 a.m.
Panel Version: 0.6019
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Combined oxidative phosphorylation deficiency 5 MIM#611719; Ovarian dysgenesis 7 MIM#618117
Publications
Gene: mrps22 has been classified as Green List (High Evidence).
Phenotypes for gene: MRPS22 were changed from to Combined oxidative phosphorylation deficiency 5, MIM# 611719
Publications for gene: MRPS22 were set to
Mode of inheritance for gene: MRPS22 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: MRPS22 was added gene: MRPS22 was added to Mitochondrial_AGHA_VCGS. Sources: Expert Review Green,Australian Genomics Health Alliance Mitochondrial Flagship,Victorian Clinical Genetics Services Mode of inheritance for gene: MRPS22 was set to Unknown